NAVBQ (Navidea Biopharmaceuticals) Common Stock: $0.29 Mil (As of Sep. 2023)


NAVBQ Navidea Biopharmaceuticals Inc NAVBQ
16 GF Score
Price $0.00
View Full Analysis

What is Navidea Biopharmaceuticals Common Stock?

Navidea Biopharmaceuticals NAVBQ -90.00% 16 Common Stock is $0.29 Mil as of Sep. 2023. GuruFocus rates NAVBQ with a GF Score™ of 16/100.

Navidea Biopharmaceuticals's quarterly common stock increased from Mar. 2023 ($0.22 Mil) to Jun. 2023 ($0.29 Mil) and increased from Jun. 2023 ($0.29 Mil) to Sep. 2023 ($0.29 Mil).

Navidea Biopharmaceuticals's annual common stock increased from Dec. 2020 ($0.22 Mil) to Dec. 2021 ($0.22 Mil) and increased from Dec. 2021 ($0.22 Mil) to Dec. 2022 ($0.22 Mil).

Navidea Biopharmaceuticals Common Stock Historical Data

* Premium members only.

The historical data trend for Navidea Biopharmaceuticals's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Navidea Biopharmaceuticals Common Stock Chart

Navidea Biopharmaceuticals Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.20 0.21 0.22 0.22 0.22

Navidea Biopharmaceuticals Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.22 0.22 0.22 0.29 0.29
NAVBQ
16GF Score
Navidea Biopharmaceuticals Inc NAVBQ
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Navidea Biopharmaceuticals Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of $0.29 Mil mean?
Navidea Biopharmaceuticals (NAVBQ) has a Common Stock of $0.29 Mil as of Sep. 2023. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Navidea Biopharmaceuticals and its competitors.
Is Navidea Biopharmaceuticals' Common Stock too high?
Navidea Biopharmaceuticals' current Common Stock is $0.29 Mil. Overall, Navidea Biopharmaceuticals has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Navidea Biopharmaceuticals' Common Stock compare to PKBO and RSPI?
Navidea Biopharmaceuticals' Common Stock of $0.29 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Biotechnology company?
A good Common Stock depends on the Biotechnology industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Navidea Biopharmaceuticals and its competitors. Navidea Biopharmaceuticals's current Common Stock is $0.29 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Navidea Biopharmaceuticals stock overvalued right now?
Navidea Biopharmaceuticals (NAVBQ) has a current Common Stock of $0.29 Mil. The current Common Stock is $0.29 Mil. Navidea Biopharmaceuticals' overall GF Score™ is 16/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Navidea Biopharmaceuticals (NAVBQ), the current Common Stock is $0.29 Mil as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Navidea Biopharmaceuticals Business Description

Address 4995 Bradenton Avenue, Suite 240, Dublin, OH, USA, 43017-3552
Navidea Biopharmaceuticals Inc is a biotechnology company specializied in precision medicine. Its products, precision immunodiagnostic agents and immunotherapeutic products are designed to assist in the identification of undetected diseases and to improve targeted treatment. The company's platform, known as Manocept technology, aims to develop next-generation targeted diagnostics and therapies for cancer, autoimmune conditions, and other inflammatory diseases. One of the company's products is Lymphoseek, a radioactive diagnostic agent indicated to locate lymph nodes.
16GF Score

Get the complete analysis for NAVBQ

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price